Search
for
Sort by
Research 181–210 of 1000+
- Targeted Inactivation of Gh/Tissue Transglutaminase II
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous adverse effects of targeted therapies
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Targeted Overexpression of the Angiogenesis Inhibitor Thrombospondin-1 in the Epidermis of Transgenic Mice Prevents Ultraviolet-B-Induced Angiogenesis and Cutaneous Photo-Damage
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Targeted transgenic expression of the mutation causing Hutchinson-Gilford progeria syndrome leads to proliferative and degenerative epidermal disease
- Targeted two-photon chemical apoptotic ablation of defined cell types in vivo
- Targeted gene delivery to skin cells in vivo: A comparative study of liposomes and polymers as delivery vehicles
- Targeted Skin Overexpression of the Mineralocorticoid Receptor in Mice Causes Epidermal Atrophy, Premature Skin Barrier Formation, Eye Abnormalities, and Alopecia
- Targeted Expression of Human Vitamin D Receptor in the Skin Promotes the Initiation of the Postnatal Hair Follicle Cycle and Rescues the Alopecia in Vitamin D Receptor Null Mice
- Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis
- Targeted Disruption of Stat3 Reveals a Major Role for Follicular Stem Cells in Skin Tumor Initiation
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Targeted disruption of Bcl‐x<sub>L</sub> in mouse keratinocytes inhibits both UVB‐ and chemically induced skin carcinogenesis
- Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Targeted delivery of a poorly water-soluble compound to hair follicles using polymeric nanoparticle suspensions
- Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles
- Targeted inactivation of integrin-linked kinase in hair follicle stem cells reveals an important modulatory role in skin repair after injury
- Targeted therapy in melanoma
- Targeted Delivery of Zinc Pyrithione to Skin Epithelia
- Targeted expression of SV40 T antigen in the hair follicle of transgenic mice produces an aberrant hair phenotype
- Targeted photosensitizer delivery: A prospective approach to vitiligo photochemotherapy
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Evaluation of the Expression of Genes Associated with Inflammation and Apoptosis in Androgenetic Alopecia by Targeted RNA-Seq
- Skin Manifestations of Targeted Antineoplastic Therapy
- Targeted elimination of the follicular label-retaining cells by photo-induced cell killing caused a defect on follicular renewal on mice
- Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis